Cogentus Pharmaceuticals News

“While it is important for patients to stay on clopidogrel to prevent the progression of coronary heart disease, ulcers and bleeding can result in patients not taking their heart disease medicine.”

Main Category: GastroIntestinal / Gastroenterology Also Included In: Conferences ; Pharma Industry / Biotech Industry Article Date: 07 May 2008 - 0:00 PDT A review of medical claims from more than 70 managed ... via Medical News Today

“This finding is consistent with our own earlier clinical data that revealed an adverse drug interaction between Plavix and Prilosec(R) (marketed omeprazole), and may raise serious concerns for patients and practitioners”

Cogentus Pharmaceuticals, Inc. today announced that dosing has begun in a clinical study to confirm the full antiplatelet activity of its novel combination medicine CGT-2168. CGT-2168 is a once-daily capsule ... via The South Mississippi Sun Herald

“We believe CGT-2168 has the potential to reduce significantly the gastrointestinal side effects that can cause patients to interrupt their treatment and further compromise their health status.”

Main Category: Cardiovascular / Cardiology Also Included In: GastroIntestinal / Gastroenterology ; Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 16 Jan 2008 - 0:00 PST ... via Medical News Today